Connection

Braden Roth to Drug Design

Back to Details
This is a "connection" page, showing publications Braden Roth has written about Drug Design.
Braden Roth
Connection Strength
0.124
Drug Design
  1. Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein. Eur J Med Chem. 2016 May 04; 113:273-92.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.